Topical antifungals may have a pharmacological effect on reducing fungal growth, colonization, and infection. However, it is unknown whether the presence of topical antifungals in a stool sample will interfere with test performance. Test interference occurs when chemical compounds, materials, or agents interfere with the performance of a test, yielding an inaccurate result. Future research is needed to examine the effect of topical antifungals on stool microbiome profiling.
Articles in this section
- How quickly can fecal calprotectin improve?
- Why is there high fecal fat malabsorption when bile acid metabolites and pancreatic enzymes are normal?
- Can beta-glucuronidase be high in females and males without hormone imbalance or disorders?
- Can the Gut Zoomer diagnose IBD?
- How long after the death of a microorganism DNA be detected?
- For fecal anti-gliadin antibodies, which gliadin peptide is measured?
- Do serum anti-gliadin antibodies always correlate with stool anti-gliadin antibodies?
- In the Gut Zoomer pathogen panel, what does the little e followed by a number refer to?
- Why would a stool specimen split sample have different results?
- I'm seeing a lot of E. Histolytica pathogen detection. How does Vibrant distinguish E. Histolytica from E. dispar?